A great balanced view with respected epidemiology Professor at the Yale School of Public Health and Yale School of Medicine’s Department of Epidemiology and Public Health
Risch has authored more than 300 original peer-reviewed publications and was formerly a member of the board of editors for the American Journal of Epidemiology.
Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment
“…people need to get angry about this… that these drugs [hydroxychloroquine, ivermectin] have been suppressed for reasons that are nothing to do with the science”
He compares length of vaccine efficacy to the treatments that he recommends should be made freely available as well.
“I’m looking at clinicians who have now treated (early) more than 150,000 patients, with fewer than 2 dozen deaths, with #hydroxychloroquine.”
In this episode, we sit down with Dr. Harvey Risch, a professor of epidemiology at the Yale School of Public Health and Yale School of Medicine. He says therapeutics, including hydroxychloroquine and ivermectin, can be highly effective against COVID when they are deployed early on and in combination with different medications.
If you have a great Youtube, Rumble or Vimeo video to share send it to videos@thebfd.co.nz
